This new role of NSMase-2 has been involved in cancer development in breast xenografts, as the blockade of the NSMase-2-mediated exosomal release from 4T1 xenografts reduced tumor growth and lung metastasis through alterations in endothelial function [46]. This evidence concerns the gene SMPD3 and cancer.